South Korean artificial intelligence (AI) software developer Vuno has signed a research and development agreement with Mayo Clinic in which the parties will work together to develop AI for precision oncology.
Vuno and Mayo Clinic will work together to develop AI and machine-learning algorithms that will enable more precise diagnosis, prognosis, and treatment stratification for patients with cancer. The partners plan to develop prognostic biomarkers that will aid in therapeutic decisions and improve the quality of cancer patient care.
